INtRON Biotechnology (Korea) Probability of Future Stock Price Finishing Over 5690.0

048530 Stock  KRW 5,610  90.00  1.58%   
INtRON Biotechnology's future price is the expected price of INtRON Biotechnology instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of iNtRON Biotechnology performance during a given time horizon utilizing its historical volatility. Check out INtRON Biotechnology Backtesting, INtRON Biotechnology Valuation, INtRON Biotechnology Correlation, INtRON Biotechnology Hype Analysis, INtRON Biotechnology Volatility, INtRON Biotechnology History as well as INtRON Biotechnology Performance.
  
Please specify INtRON Biotechnology's target price for which you would like INtRON Biotechnology odds to be computed.

INtRON Biotechnology Target Price Odds to finish over 5690.0

The tendency of INtRON Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over W 5,690  or more in 90 days
 5,610 90 days 5,690 
about 81.54
Based on a normal probability distribution, the odds of INtRON Biotechnology to move over W 5,690  or more in 90 days from now is about 81.54 (This iNtRON Biotechnology probability density function shows the probability of INtRON Stock to fall within a particular range of prices over 90 days) . Probability of iNtRON Biotechnology price to stay between its current price of W 5,610  and W 5,690  at the end of the 90-day period is about 6.11 .
Assuming the 90 days trading horizon INtRON Biotechnology has a beta of 0.0128. This suggests as returns on the market go up, INtRON Biotechnology average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding iNtRON Biotechnology will be expected to be much smaller as well. Additionally INtRON Biotechnology has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   INtRON Biotechnology Price Density   
       Price  

Predictive Modules for INtRON Biotechnology

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as iNtRON Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
5,6085,6105,612
Details
Intrinsic
Valuation
LowRealHigh
4,7664,7686,171
Details
Naive
Forecast
LowNextHigh
5,6525,6545,656
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
5,5555,6405,725
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as INtRON Biotechnology. Your research has to be compared to or analyzed against INtRON Biotechnology's peers to derive any actionable benefits. When done correctly, INtRON Biotechnology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in iNtRON Biotechnology.

INtRON Biotechnology Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. INtRON Biotechnology is not an exception. The market had few large corrections towards the INtRON Biotechnology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold iNtRON Biotechnology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of INtRON Biotechnology within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.23
β
Beta against Dow Jones0.01
σ
Overall volatility
307.82
Ir
Information ratio -0.18

INtRON Biotechnology Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of INtRON Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for iNtRON Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
iNtRON Biotechnology generated a negative expected return over the last 90 days
About 16.0% of the company shares are owned by insiders or employees

INtRON Biotechnology Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of INtRON Stock often depends not only on the future outlook of the current and potential INtRON Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. INtRON Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding33.7 M
Cash And Short Term Investments83.5 B
Shares Float26.7 M

INtRON Biotechnology Technical Analysis

INtRON Biotechnology's future price can be derived by breaking down and analyzing its technical indicators over time. INtRON Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of iNtRON Biotechnology. In general, you should focus on analyzing INtRON Stock price patterns and their correlations with different microeconomic environments and drivers.

INtRON Biotechnology Predictive Forecast Models

INtRON Biotechnology's time-series forecasting models is one of many INtRON Biotechnology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary INtRON Biotechnology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about iNtRON Biotechnology

Checking the ongoing alerts about INtRON Biotechnology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for iNtRON Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
iNtRON Biotechnology generated a negative expected return over the last 90 days
About 16.0% of the company shares are owned by insiders or employees

Other Information on Investing in INtRON Stock

INtRON Biotechnology financial ratios help investors to determine whether INtRON Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in INtRON with respect to the benefits of owning INtRON Biotechnology security.